Zohre Labbani-Motlagh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zohre Labbani-Motlagh has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Shahideh Amini
Fellowship of Pharmacotherapy in Critical Care, Rajaie Cardiovascular Medical and Research Institute, Tehran, Iran
2 shared publications Alireza Naserian
Tehran University of Medical Sciences
1 shared publication- Azin Abdollahi
Faculty of Pharmacy Tehran University of Medical Science (TUMS) Tehran Iran
1 shared publication Hadieh Tazerouni
Tehran University of Medical Sciences
1 shared publication- Hossein Khalili
Department of Clinical Pharmacy, Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran
1 shared publication - Iman Karimzadeh
Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication
Latest Publications
- Open Access
- 23 May 2024
- Published by Wiley
A case report of drug-Induced hemorrhagic bullae
A case report of drug-Induced hemorrhagic bullae
- 23 May 2024
- Published by Wiley
Open AccessA case report of drug-Induced hemorrhagic bullae
A case report of drug-Induced hemorrhagic bullae
- Open Access
- 5 September 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (9) , e6283
Case series of nebulizing r‐tPA for COVID‐19 induced acute respiratory distress syndrome
Fibrin deposition in the alveolar spaces during pulmonary involvement of COVID‐19 impairs the O2/CO2 exchange and leads to respiratory symptoms. In this report, Recombinant Tissue Plasminogen Activator (r‐tPA) has been nebulized to 3 critically ill COVID‐19 patients in order to resolve the deposited fibrin while avoiding the risk of bleeding. Based on these observations, nebulization of r‐tPA may be a potential therapeutic approach and new area of research for future studies.
- 5 September 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (9) , e6283
Open AccessCase series of nebulizing r‐tPA for COVID‐19 induced acute respiratory distress syndrome
Fibrin deposition in the alveolar spaces during pulmonary involvement of COVID‐19 impairs the O2/CO2 exchange and leads to respiratory symptoms. In this report, Recombinant Tissue Plasminogen Activator (r‐tPA) has been nebulized to 3 critically ill COVID‐19 patients in order to resolve the deposited fibrin while avoiding the risk of bleeding. Based on these observations, nebulization of r‐tPA may be a potential therapeutic approach and new area of research for future studies.
- Open Access
- 1 August 2020
- Published by Knowledge E DMCC in Journal of Pharmaceutical Care
Reconsideration of Interactions Between Direct Oral Anticoagulants and Calcineurin Inhibitors
This article is a Letter to the Editor and does not include an
- 1 August 2020
- Published by Knowledge E DMCC in Journal of Pharmaceutical Care
Open AccessReconsideration of Interactions Between Direct Oral Anticoagulants and Calcineurin Inhibitors
This article is a Letter to the Editor and does not include an
- 1 June 2020
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 9 (9) , 627-637
Types and outcomes of cytopenia in critically ill patients
Cytopenia is common complication in critically ill patients. Aim: Incidence and pattern of different types of cytopenia as well as its impact on mortality and length of stay in critically ill patients were evaluated. Methods: Critically ill patients with any kind of cytopenia for more than 2 days were evaluated. Results: Anemia was the most common type of cytopenia in the patients (99.14%), followed by lymphocytopenia (32.17%), thrombocytopenia (27.82%), and leukopenia (19.13%). Mortality rate was significantly higher in patients with anemia (p < 0.0001), thrombocytopenia (p < 0.0001), leukopenia (p < 0.0001), neutropenia (p = 0.004), lymphopenia (p = 0.002) and pancytopenia (p < 0.0001). Higher duration of anemia, lymphopenia and thrombocytopenia were associated with longer intensive care unit stay (p < 0.0001, p < 0.0001 and p < 0.001, respectively). Conclusion: Among all assessed variables, incidence of thrombocytopenia could independently predict the mortality.
- 1 June 2020
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 9 (9) , 627-637
Types and outcomes of cytopenia in critically ill patients
Cytopenia is common complication in critically ill patients. Aim: Incidence and pattern of different types of cytopenia as well as its impact on mortality and length of stay in critically ill patients were evaluated. Methods: Critically ill patients with any kind of cytopenia for more than 2 days were evaluated. Results: Anemia was the most common type of cytopenia in the patients (99.14%), followed by lymphocytopenia (32.17%), thrombocytopenia (27.82%), and leukopenia (19.13%). Mortality rate was significantly higher in patients with anemia (p < 0.0001), thrombocytopenia (p < 0.0001), leukopenia (p < 0.0001), neutropenia (p = 0.004), lymphopenia (p = 0.002) and pancytopenia (p < 0.0001). Higher duration of anemia, lymphopenia and thrombocytopenia were associated with longer intensive care unit stay (p < 0.0001, p < 0.0001 and p < 0.001, respectively). Conclusion: Among all assessed variables, incidence of thrombocytopenia could independently predict the mortality.
- Open Access
- 7 April 2020
- Published by Springer Nature in Research Square
Assessment of Anti-oxidant and Anti-inflammatory Properties of Green Tea in Critically Ill Patients with Pneumonia
Background: Systemic inflammatory response syndrome is common in critically ill patients and negatively affects clinical outcomes. Preventing oxidative damage, may suppress this systemic response. Previous studies confirmed that polyphenols in green tea have both antioxidant and immuno-stimulant effect, so there could be a probability of green tea clinical application. Two groups of 8 patients enrolled in this randomized, controlled clinical trial. Treatment group received Green Tea Extract (GTE), and placebo group received extract's solvent for 7 days. Blood samples taken 3 times/week and oxidative, physiologic and inflammatory markers were measured. Results: Differences between the baselines for each variable were not significant. FRAP value showed slower decrease in GTE group. Thiol level increased in GTE group and decreased in Placebo group. IL-6 and APACHE II score were lower in GTE group on day7. Leucocyte count showed overall increase in GTE group and decrease in placebo group. Differences between two groups in all aforementioned variables were statistically insignificant.Conclusion: As a conclusion green tea had no significant effect on all measured variables; but in GTE group despite better oxidative status in the first 3 days, more inflammation was observed on day7. Considering small sample size further investigations are needed.
- 7 April 2020
- Published by Springer Nature in Research Square
Open AccessAssessment of Anti-oxidant and Anti-inflammatory Properties of Green Tea in Critically Ill Patients with Pneumonia
Background: Systemic inflammatory response syndrome is common in critically ill patients and negatively affects clinical outcomes. Preventing oxidative damage, may suppress this systemic response. Previous studies confirmed that polyphenols in green tea have both antioxidant and immuno-stimulant effect, so there could be a probability of green tea clinical application. Two groups of 8 patients enrolled in this randomized, controlled clinical trial. Treatment group received Green Tea Extract (GTE), and placebo group received extract's solvent for 7 days. Blood samples taken 3 times/week and oxidative, physiologic and inflammatory markers were measured. Results: Differences between the baselines for each variable were not significant. FRAP value showed slower decrease in GTE group. Thiol level increased in GTE group and decreased in Placebo group. IL-6 and APACHE II score were lower in GTE group on day7. Leucocyte count showed overall increase in GTE group and decrease in placebo group. Differences between two groups in all aforementioned variables were statistically insignificant.Conclusion: As a conclusion green tea had no significant effect on all measured variables; but in GTE group despite better oxidative status in the first 3 days, more inflammation was observed on day7. Considering small sample size further investigations are needed.